Kazuko Kamiyama

639 total citations
18 papers, 500 citations indexed

About

Kazuko Kamiyama is a scholar working on Molecular Biology, Nephrology and Pathology and Forensic Medicine. According to data from OpenAlex, Kazuko Kamiyama has authored 18 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Nephrology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Kazuko Kamiyama's work include Chronic Kidney Disease and Diabetes (4 papers), Renal Diseases and Glomerulopathies (4 papers) and Chemotherapy-induced organ toxicity mitigation (4 papers). Kazuko Kamiyama is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Renal Diseases and Glomerulopathies (4 papers) and Chemotherapy-induced organ toxicity mitigation (4 papers). Kazuko Kamiyama collaborates with scholars based in Japan and China. Kazuko Kamiyama's co-authors include Daisuke Mikami, Masayuki Iwano, Hideki Kimura, Mamiko Kobayashi, Takanobu Taniguchi, Naoki Takahashi, Kenji Kasuno, Seiji Yokoi, Yukie Morikawa and Yoshiharu Machida and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Life Sciences.

In The Last Decade

Kazuko Kamiyama

18 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kazuko Kamiyama Japan 13 280 132 64 54 52 18 500
Konica Porwal India 18 409 1.5× 77 0.6× 34 0.5× 44 0.8× 85 1.6× 39 742
Shui-juan Zhang China 17 250 0.9× 70 0.5× 36 0.6× 24 0.4× 32 0.6× 26 525
Jiaxing Zhang China 14 220 0.8× 84 0.6× 36 0.6× 22 0.4× 95 1.8× 29 575
Shyamsundar Pal China India 14 293 1.0× 97 0.7× 38 0.6× 63 1.2× 61 1.2× 25 521
Ahmed Shata Egypt 14 274 1.0× 58 0.4× 62 1.0× 65 1.2× 89 1.7× 32 554
Mamiko Kobayashi Japan 9 232 0.8× 123 0.9× 60 0.9× 40 0.7× 42 0.8× 24 419
Haifeng Zhang China 11 345 1.2× 59 0.4× 53 0.8× 36 0.7× 82 1.6× 28 706
Filomena G. Ottaviano United States 8 258 0.9× 69 0.5× 61 1.0× 38 0.7× 47 0.9× 9 614

Countries citing papers authored by Kazuko Kamiyama

Since Specialization
Citations

This map shows the geographic impact of Kazuko Kamiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuko Kamiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuko Kamiyama more than expected).

Fields of papers citing papers by Kazuko Kamiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuko Kamiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuko Kamiyama. The network helps show where Kazuko Kamiyama may publish in the future.

Co-authorship network of co-authors of Kazuko Kamiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuko Kamiyama. A scholar is included among the top collaborators of Kazuko Kamiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuko Kamiyama. Kazuko Kamiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kimura, Hideki, Kazuko Kamiyama, Mamiko Kobayashi, et al.. (2024). Dichloroacetate reduces cisplatin-induced apoptosis by inhibiting the JNK/14-3-3/Bax/caspase-9 pathway and suppressing caspase-8 activation via cFLIP in murine tubular cells. Scientific Reports. 14(1). 24307–24307. 3 indexed citations
2.
Matsuta, K, Kazuko Kamiyama, Mamiko Kobayashi, et al.. (2024). PPAR-α Insufficiency Enhances Doxorubicin-Induced Nephropathy in PPAR-α Knockout Mice and a Murine Podocyte Cell Line. Cells. 13(17). 1446–1446. 4 indexed citations
3.
Kimura, Hideki, Kazuko Kamiyama, Mamiko Kobayashi, et al.. (2022). Fenofibrate reduces cisplatin-induced apoptosis by inhibiting the p53/Puma/Caspase-9 pathway and the MAPK/Caspase-8 pathway rather than by promoting autophagy in murine renal proximal tubular cells. Biochemistry and Biophysics Reports. 30. 101237–101237. 8 indexed citations
4.
Kimura, Hideki, Seiji Yokoi, Kazuko Kamiyama, et al.. (2021). PPAR-δ activation reduces cisplatin-induced apoptosis via inhibiting p53/Bax/caspase-3 pathway without modulating autophagy in murine renal proximal tubular cells. Clinical and Experimental Nephrology. 25(6). 598–607. 7 indexed citations
5.
Takahashi, Naoki, Haruyoshi Yoshida, Hideki Kimura, et al.. (2020). Chronic hypoxia exacerbates diabetic glomerulosclerosis through mesangiolysis and podocyte injury in db/db mice. Nephrology Dialysis Transplantation. 35(10). 1678–1688. 16 indexed citations
6.
Mikami, Daisuke, Mamiko Kobayashi, Junsuke Uwada, et al.. (2020). Short-chain fatty acid mitigates adenine-induced chronic kidney disease via FFA2 and FFA3 pathways. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(6). 158666–158666. 29 indexed citations
7.
Mikami, Daisuke, Mamiko Kobayashi, Junsuke Uwada, et al.. (2020). AR420626, a selective agonist of GPR41/FFA3, suppresses growth of hepatocellular carcinoma cells by inducing apoptosis via HDAC inhibition. Therapeutic Advances in Medical Oncology. 12. 3863528472–3863528472. 18 indexed citations
8.
Mikami, Daisuke, Mamiko Kobayashi, Junsuke Uwada, et al.. (2019). β-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cells. Journal of Pharmacological Sciences. 142(1). 1–8. 30 indexed citations
9.
Mikami, Daisuke, Mamiko Kobayashi, Junsuke Uwada, et al.. (2019). β-Hydroxybutyrate, a ketone body, reduces the cytotoxic effect of cisplatin via activation of HDAC5 in human renal cortical epithelial cells. Life Sciences. 222. 125–132. 24 indexed citations
10.
Kobayashi, Mamiko, Daisuke Mikami, Junsuke Uwada, et al.. (2018). A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells. Oncotarget. 9(59). 31342–31354. 56 indexed citations
11.
Morikawa, Yukie, Naoki Takahashi, Kazuko Kamiyama, et al.. (2018). Elevated Levels of Urinary Extracellular Vesicle Fibroblast-Specific Protein 1 in Patients with Active Crescentic Glomerulonephritis. ˜The œNephron journals/Nephron journals. 141(3). 177–187. 14 indexed citations
12.
Kobayashi, Mamiko, Daisuke Mikami, Hideki Kimura, et al.. (2017). Short-chain fatty acids, GPR41 and GPR43 ligands, inhibit TNF-α-induced MCP-1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells. Biochemical and Biophysical Research Communications. 486(2). 499–505. 159 indexed citations
13.
Kimura, Hideki, Koji Oida, Hideo Kanehara, et al.. (2016). Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association. Lipids in Health and Disease. 15(1). 57–57. 12 indexed citations
14.
Kimura, Hideki, Daisuke Mikami, Kazuko Kamiyama, et al.. (2014). Telmisartan, a possible PPAR-δ agonist, reduces TNF-α-stimulated VEGF-C production by inhibiting the p38MAPK/HSP27 pathway in human proximal renal tubular cells. Biochemical and Biophysical Research Communications. 454(2). 320–327. 13 indexed citations
15.
Mikami, Daisuke, Hideki Kimura, Kazuko Kamiyama, et al.. (2013). Telmisartan activates endogenous peroxisome proliferator-activated receptor-δ and may have anti-fibrotic effects in human mesangial cells. Hypertension Research. 37(5). 422–431. 28 indexed citations
16.
Kimura, Hideki, Xuan Li, Kunio Torii, et al.. (2010). Glucocorticoid enhances hypoxia- and/or transforming growth factor-β-induced plasminogen activator inhibitor-1 production in human proximal renal tubular cells. Clinical and Experimental Nephrology. 15(1). 34–40. 11 indexed citations
17.
Kimura, Hideki, Xuan Li, Kunio Torii, et al.. (2009). Dexamethasone enhances basal and TNF-α-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11β-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells. Nephrology Dialysis Transplantation. 24(6). 1759–1765. 13 indexed citations
18.
Kamiyama, Kazuko, Hiraku Onishi, & Yoshiharu Machida. (1999). Biodisposition Characteristics of N-Succinyl-chitosan and Glycol-chitosan in Normal and Tumor-bearing Mice.. Biological and Pharmaceutical Bulletin. 22(2). 179–186. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026